January 24, 2023
Discussing Dietary Supplements with Patients
Given the vast array of dietary supplements on the market—some of which may be ineffective or potentially harmful—it’s more important than ever to discuss these products with patients.
Tag: FDA
January 24, 2023
Given the vast array of dietary supplements on the market—some of which may be ineffective or potentially harmful—it’s more important than ever to discuss these products with patients.
March 10, 2021
Experts say patient-centric opioid intervention before discharge from the hospital can cut overall opioid intake, while still ensuring a patient is satisfied and their pain is properly managed.
March 3, 2021
The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.
February 18, 2021
The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.
January 26, 2021
The U.S. Food and Drug Administration released an AI/ML-Based Software as a Medical Device Action Plan, which outlines a detailed approach to ensuring the safety and efficacy of these technologies.
December 15, 2020
The U.S. Food and Drug Administration cautions that patients can be injured if wearing face masks with metal features or coating during an MRI exam.
November 11, 2020
The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.
October 28, 2020
The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.
October 2, 2020
Dental amalgam is “durable, safe and effective” despite containing mercury, the American Dental Association reaffirmed, responding to a recent statement by the Food and Drug Administration.
September 30, 2020
The FDA cautions that a number of websites are illegally selling unauthorized opioids that may be counterfeit, contaminated, expired or otherwise unsafe.